Parkinson’s Disease and CBD Oil
Parkinson disease (PD) is a disabling disorder that has spread rapidly and progressively across United States, making it one that greatly warrants the study of its cure. Fortunately, cannabidiol (CBD) has been studied to be quite effective in treating Parkinson’s, and this content implicitly elucidates its tolerability and efficacy. This content is a summary of the research from Colorado Multiple Institutional Review Board. It is however crucial to intimate that the information you will be reading in this content is not our idea, and the full research can be read here: https://clinicaltrials.gov/ProvidedDocs/77/NCT02818777/Prot_SAP_000.pdf
The relationship between Parkinson’s Disease and CBD oil has been meticulously studied ever since cannabis became legal in many states. Published and anecdotal reports carried out with regard to CBD proved that it has numerous potential medical benefits. People that are sufferers of Parkinson’s also develop progressive disabling tremor, balance impairment, slowness, psychiatric symptoms, insomnia, cognitive deficits, stiffness, fatigue, and autonomic dysfunction. This has caused reduction in the quality of life of affected people and their caregivers.
Studying Parkinson’s Disease and CBD Oil
Studying Parkinson’s Disease and CBD oil in this study showed that CBD oil greatly improves the prognosis of Parkinson’s disease. Through the systematic review of medical marijuana carried out by the American Academy of Neurology (AAN) Guideline Development Subcommittee, some essential facts were gathered. Quite simply, in a number of experimental models, CBD acts as an anti-oxidant, anti-inflammatory, anti-emetic, anticonvulsant, antipsychotic and anxiolytic agent, making it a substance with numerous potential health-wise benefits. The study of Parkinson’s Disease and CBD oil has also made it conspicuous that CBD is neuroprotective, which is most likely due to its anti-oxidative and anti-inflammatory actions.
Furthermore, report gathered from human trials proved that CBD causes sedation, reduction in anxiety, reduction in psychotic symptoms of sufferers of schizophrenia and Parkinson’s disease. Additionally, this study shows that CBD enhances motor and non-motor symptoms, as well as the alleviation of levodopa-induced dyskinesia in Parkinson’s disease.
Works Cited
COMIRB. (2017). A randomized, double blind, placebo-controlled crossover study of tolerability and efficacy. COLORADO MULTIPLE INSTITUTIONAL REVIEW BOARD.
